Short‐acting erythropoiesis‐stimulating agents for anaemia in predialysis patients

BACKGROUND: The benefits of erythropoiesis‐stimulating agents (ESA) for chronic kidney disease (CKD) patients have been previously demonstrated. However, the efficacy and safety of short‐acting epoetins administered at larger doses and reduced frequency as well as of new epoetins and biosimilars rem...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cochrane Database Syst Rev
Main Authors: Hahn, Deirdre, Esezobor, Christopher I, Elserafy, Noha, Webster, Angela C, Hodson, Elisabeth M
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Ltd 2017
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464724/
https://ncbi.nlm.nih.gov/pubmed/28066881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011690.pub2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker